Search clinical trials for: Regulatory Post Marketing Commitment Plan

Total 71520 results

Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)

Pain Associated With Fibromyalgia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan) (RAINBOW-L)

Neuropathic Pain
Pfizer

Completed

Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

Acromegaly
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan) (RAINBOW)

Neuralgia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension

Ocular Hypertension | Glaucoma
Pfizer

Completed

Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

Carcinoma, Renal Cell
Pfizer

Completed

Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).

Gastrointestinal Stromal Tumors
Pfizer

Completed

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Transthyretin Familial Amyloid Poluneuropathy
Pfizer

Completed

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Pfizer

Completed

Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication (DREAM)

Deep Mycosis
Pfizer

Completed

Drug Use Investigation for Toviaz

Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)

Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)

Pulmonary Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Hypertension | Angina Pectoris | Hypercholesterolemia | Familial Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (ESSENCE)

Hypertension
ViiV Healthcare
Pfizer

Completed

Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)

CCR5-tropic HIV-1 Infection
Pfizer

Completed

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Non-small Cell Lung Cancer
Pfizer

Completed

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan) (VIOLINE)

Osteoporosis
Pfizer

Completed

BeneFIX Drug Use Results Survey [All-Case Surveillance]

Hemophilia B

Japan
Pfizer

Completed

Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Renal Cell Carcinoma

Japan
Pfizer

Completed

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid | High Dose

Japan
Pfizer

Completed

Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan) (RESCUE-L)

Legionnaires' Disease | Legionella Pneumophila Infections
Pfizer

Completed

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (RESCUE)

Pneumonia | Pelvic Inflammatory Disease
Pfizer

Completed

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid

Japan
Pfizer

Completed

Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Pfizer

Completed

Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Pfizer

Completed

Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Scedosporium Infection
Pfizer

Completed

Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Systemic Mycosis
Pfizer

Completed

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

Urinary Bladder, Overactive
Pfizer

Completed

Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)

Staphylococcal Infections
Pfizer

Completed

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Bacterial Infections
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) (POTTOR)

Overactive Bladder
Pfizer

Completed

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Streptococcus Pneumoniae | Pneumococcal Vaccine

Japan
The Royal Orthopaedic Hospital NHS Trust

Recruiting

Patient Specific Guides and Surgical Planning for Periacetabular Osteotomy; Post Marketing Evaluation Study (MyPAO)

Acetabular Dysplasia | Periacetabular Osteotomy | Pelvic Osteotomy

United Kingdom
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

Breast Cancer

United States, Puerto Rico
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
Novartis Pharmaceuticals

Recruiting

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

Korea, Republic of
Novartis Pharmaceuticals

Recruiting

Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity

Retinopathy of Prematurity

Korea, Republic of
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Endovascular Embolization of Chronic Subdural Hematomas After Surgery (ENCLOSURE)

Chronic Subdural Hematoma

Spain
Pfizer

Recruiting

Korean Regulatory Post Marketing Surveillance for Somavert

Acromegaly

Korea, Republic of
B. Braun Melsungen AG

Recruiting

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Central Venous Catheter

Germany, Italy
Novartis Pharmaceuticals

Recruiting

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Neovascular Age-related Macular Degeneration

Korea, Republic of
AstraZeneca

Recruiting

'OLAP' (OLAparib Regulatory Post-marketing Surveillance) (OLAP)

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer

Korea, Republic of
Novartis Pharmaceuticals

Recruiting

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Fascioliasis

Vietnam, Egypt, Colombia, Peru
Zhong Wang

Recruiting

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Adverse Drug Event | Adverse Drug Reactions | Severe Adverse Reactions | Anaphylactic Reaction

China
AstraZeneca

Completed

QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing Surveillance

Type 2 Diabetes Mellitus

Korea, Republic of
Novartis Pharmaceuticals

Active, not recruiting

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab (ARTIOS)

Relapsing Multiple Sclerosis

United States, Poland, Austria, Belgium, Czechia, Germany, Australia, Switzerland, Lebanon, Argentina, Canada, Slovenia, Bulgaria, Latvia, Russian Federation, Spain, Italy, Turkey, Slovakia, Portugal, Greece, Saudi Arabia, Hungary, No... and more
Pfizer

Active, not recruiting

Korea Comirnaty Post-marketing Surveillance

COVID-19 | SARS-CoV-2 | Adverse Effects | Safety | Vaccines

Korea, Republic of
Geisinger Clinic

Completed

Evaluation of a Letter Intervention Promoting a Plant-based Diet

Cardiovascular Diseases | Obesity | Diabetes Mellitus

United States

3

Subscribe